Evaluation of the density spectral array in the Wada test: report of six cases

Pacreu, Susana; Vilà, Esther; Moltó, Luis; Rocamora Zúñiga, Rodrigo Alberto; Fernández-Candil, Juan-Luis

doi:http://dx.doi.org/10.1016/j.bjane.2021.02.050

Evaluation of the density spectral array in the Wada test: report of six cases

License

Citation

Pacreu S, Vilà E, Moltó L, Rocamora R, Fernández-Candil JL. Evaluation of the density spectral array in the Wada test: report of six cases. Braz J Anesthesiol. 2021;71(3):288-91. DOI: 10.1016/j.bjane.2021.02.050

Abstract

Wada test is an invasive procedure used in the preoperative evaluation for epilepsy surgery to determine language lateralization, postoperative risk of amnesia syndrome, and to assess the risk of memory deficits. It involves injection of amobarbital into internal carotid artery of the affected hemisphere followed by the healthy hemisphere to shut down brain function. We performed an observational study evaluating the density spectral array (DSA) of the bilateral bispectral index VISTA™ Monitoring System (BVMS) in 6 patients with drug-resistant epilepsy undergoing Wada test. DSA revealed the presence of bifrontal alpha waves in absence of loss of consciousness in all patients.